GB9918912D0 - New stilbenes with vascular damaging activity - Google Patents

New stilbenes with vascular damaging activity

Info

Publication number
GB9918912D0
GB9918912D0 GBGB9918912.8A GB9918912A GB9918912D0 GB 9918912 D0 GB9918912 D0 GB 9918912D0 GB 9918912 A GB9918912 A GB 9918912A GB 9918912 D0 GB9918912 D0 GB 9918912D0
Authority
GB
United Kingdom
Prior art keywords
stilbenes
new
vascular damaging
damaging activity
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9918912.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiogene Pharmaceuticals Ltd
Original Assignee
Angiogene Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiogene Pharmaceuticals Ltd filed Critical Angiogene Pharmaceuticals Ltd
Priority to GBGB9918912.8A priority Critical patent/GB9918912D0/en
Publication of GB9918912D0 publication Critical patent/GB9918912D0/en
Priority to CA002379544A priority patent/CA2379544A1/en
Priority to PCT/GB2000/003067 priority patent/WO2001012579A2/en
Priority to JP2001516880A priority patent/JP2003507356A/en
Priority to NZ517069A priority patent/NZ517069A/en
Priority to EP00951727A priority patent/EP1206429A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
GBGB9918912.8A 1999-08-12 1999-08-12 New stilbenes with vascular damaging activity Ceased GB9918912D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9918912.8A GB9918912D0 (en) 1999-08-12 1999-08-12 New stilbenes with vascular damaging activity
CA002379544A CA2379544A1 (en) 1999-08-12 2000-08-09 New stilbenes with vascular damaging activity
PCT/GB2000/003067 WO2001012579A2 (en) 1999-08-12 2000-08-09 New stilbenes with vascular damaging activity
JP2001516880A JP2003507356A (en) 1999-08-12 2000-08-09 New stilbenes with vascular damage activity
NZ517069A NZ517069A (en) 1999-08-12 2000-08-09 New stilbenes with vascular damaging activity
EP00951727A EP1206429A2 (en) 1999-08-12 2000-08-09 Stilbenes with vascular damaging activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9918912.8A GB9918912D0 (en) 1999-08-12 1999-08-12 New stilbenes with vascular damaging activity

Publications (1)

Publication Number Publication Date
GB9918912D0 true GB9918912D0 (en) 1999-10-13

Family

ID=10858950

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9918912.8A Ceased GB9918912D0 (en) 1999-08-12 1999-08-12 New stilbenes with vascular damaging activity

Country Status (6)

Country Link
EP (1) EP1206429A2 (en)
JP (1) JP2003507356A (en)
CA (1) CA2379544A1 (en)
GB (1) GB9918912D0 (en)
NZ (1) NZ517069A (en)
WO (1) WO2001012579A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1140272C (en) 1998-04-03 2004-03-03 味之素株式会社 Antitumor agents
GB0019944D0 (en) 2000-08-15 2000-09-27 Angiogene Pharm Ltd Compositions with vascular damaging activity
CA2432640A1 (en) 2000-12-21 2002-06-27 Cancer Research Technology Limited Substituted stilbenes, their reactions and anticancer activity
FR2838437B1 (en) 2002-04-11 2004-06-04 Aventis Pharma Sa PROCESSES FOR THE PREPARATION OF COMBRETASTATINS
GB0306908D0 (en) * 2003-03-26 2003-04-30 Angiogene Pharm Ltd Bioreductively activated stilbene prodrugs
KR20060115325A (en) 2003-12-16 2006-11-08 지티엑스, 인코포레이티드 Prodrugs of selective androgen receptor modulators and methods of use thereof
CN1723884A (en) * 2004-07-21 2006-01-25 中国人民解放军军事医学科学院放射医学研究所 Cis-1, the diphenyl ethylene derivatives that 2-replaces are used to prepare the purposes of the medicine of treatment or prevent diabetes
CN101085743B (en) * 2006-06-06 2012-02-15 浙江大德药业集团有限公司 Fluorine-containing alkoxy combretastatin derivative, preparation method and use thereof
PL2219451T3 (en) 2007-11-21 2015-04-30 Oxigene Inc Method for treating hematopoietic neoplasms
JP2011016777A (en) * 2009-07-10 2011-01-27 Nipro Corp New cysteine derivative
EP2609089A1 (en) 2010-08-27 2013-07-03 Universität des Saarlandes Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
EP2972394A4 (en) 2013-03-15 2016-11-02 Sloan Kettering Inst Cancer Hsp90-targeted cardiac imaging and therapy
JP2018523712A (en) 2015-08-18 2018-08-23 マテオン セラピューティクス, インク.Mateon Therapeutics, Inc. Use of VDAS to improve immunomodulatory therapy against tumors
WO2017197045A1 (en) 2016-05-11 2017-11-16 Movassaghi Mohammad Convergent and enantioselective total synthesis of communesin analogs
WO2018209239A1 (en) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
EP3874064A1 (en) 2018-10-29 2021-09-08 Cepheid Exponential base-3 nucleic acid amplification with reduced amplification time using nested overlapping primers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106177D0 (en) * 1991-03-22 1991-05-08 Aston Molecules Ltd Substituted diphenylethylenes and analogues or derivatives thereof
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5561122A (en) * 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
GB9903403D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Substituted stilbene compounds with vascular damaging activity

Also Published As

Publication number Publication date
CA2379544A1 (en) 2001-02-22
WO2001012579A2 (en) 2001-02-22
EP1206429A2 (en) 2002-05-22
NZ517069A (en) 2004-04-30
JP2003507356A (en) 2003-02-25
WO2001012579A3 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
GB9918912D0 (en) New stilbenes with vascular damaging activity
IL186608A0 (en) Igf-like insulin variant
IL152682A0 (en) Indole derivatives with vascular damaging activity
HUP0300290A3 (en) Combination therapies with vascular damaging activity
SG93875A1 (en) Showcase
GB9922610D0 (en) Improved showcase
EP1296704A4 (en) Peptides with physiological activity
GB0009753D0 (en) Dishwasher with removable basket
HK1047940A1 (en) 9A-azalides with antibacterial activity
SG87161A1 (en) Absorptive article
GB0029012D0 (en) Dishwasher
HUP0300576A3 (en) Divided dose therapies with vascular damaging activity
GB9927711D0 (en) Vascular occluder
GB2356131B (en) Dishwasher
GB2358390B (en) Storage assembly
GB2351756B (en) Trellis assemblies
GB9921764D0 (en) Syringe
GB0027081D0 (en) Solution
SI1272200T1 (en) Divided dose therapies with vascular damaging activity
TW369844U (en) Modified shelf structure
TW404218U (en) Dish structure
CA85594S (en) Syringe
TW386417U (en) Juicer structure
PL336556A1 (en) Case with drawers
ZA99106B (en) Vascular damaging agents.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)